open access

Vol 10, No 2 (2015)
Review Papers
Published online: 2015-05-22
Get Citation

The standardized tomato concentrate therapy in primary cardiovascular disease prevention. Is it an alternative to aspirin and for whom? An expert consensus document

Beata Wożakowska-Kapłon, Krzysztof J. Filipiak, Artur Mamcarz, Krzysztof Narkiewicz, Andrzej Tykarski, Krystyna Widecka
DOI: 10.5603/FC.2015.0015
·
Folia Cardiologica 2015;10(2):100-105.

open access

Vol 10, No 2 (2015)
Review Papers
Published online: 2015-05-22

Abstract

The use of acetylsalicylid acid (ASA) in primary cardiovascular (CV) prevention has been abandoned due to the lack of a favorable benefit-to-risk ratio. The indications for ASA use in this setting continue to be a source of major debate. The data indicate that standardized tomato extract (STE) contains very potent anti-platelet components. As a functional food or dietary supplement, STE may have a role in primary prevention of cardiovascular disease (CVD) by reducing platelet activation, which could contribute to a reduction in thrombotic events. While awaiting the results of several ongoing studies with ASA, an expert consensus document for an approach to using STE in primary CV prevention in selected groups of people is presented.

Abstract

The use of acetylsalicylid acid (ASA) in primary cardiovascular (CV) prevention has been abandoned due to the lack of a favorable benefit-to-risk ratio. The indications for ASA use in this setting continue to be a source of major debate. The data indicate that standardized tomato extract (STE) contains very potent anti-platelet components. As a functional food or dietary supplement, STE may have a role in primary prevention of cardiovascular disease (CVD) by reducing platelet activation, which could contribute to a reduction in thrombotic events. While awaiting the results of several ongoing studies with ASA, an expert consensus document for an approach to using STE in primary CV prevention in selected groups of people is presented.

Get Citation

Keywords

standardized tomato extract, cardiovascular prevention

About this article
Title

The standardized tomato concentrate therapy in primary cardiovascular disease prevention. Is it an alternative to aspirin and for whom? An expert consensus document

Journal

Folia Cardiologica

Issue

Vol 10, No 2 (2015)

Pages

100-105

Published online

2015-05-22

DOI

10.5603/FC.2015.0015

Bibliographic record

Folia Cardiologica 2015;10(2):100-105.

Keywords

standardized tomato extract
cardiovascular prevention

Authors

Beata Wożakowska-Kapłon
Krzysztof J. Filipiak
Artur Mamcarz
Krzysztof Narkiewicz
Andrzej Tykarski
Krystyna Widecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl